Skip to main
USPH
USPH logo

USPH Stock Forecast & Price Target

USPH Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 75%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

US Physical Therapy Inc. has demonstrated a positive financial trajectory, highlighted by a sequential increase in commercial pricing of 2.2%. Additionally, revenue from the Industrial Injury Prevention (IIP) segment has seen robust growth, increasing by 22.2% overall and 18.4% when excluding merger and acquisition contributions. Moreover, the company has successfully improved its net rate for the recently acquired Metro business, rising from approximately $101 to $107.50, indicating strong operational performance and strategic positioning.

Bears say

US Physical Therapy has experienced a 0.6% decline in a key financial metric, dropping from $84.46 to $83.95 compared to the previous year. The company has faced persistent reimbursement cuts over the past five years, cumulatively impacting profitability by $20 million, which continues to weigh heavily on its financial outlook. Additionally, operating expenses related to rent and clinic costs have risen to 20.2% of revenue, surpassing initial estimates, further straining the company's financial performance.

USPH has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 75% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About U.S. Physical Therapy (USPH) Forecast

Analysts have given USPH a Buy based on their latest research and market trends.

According to 4 analysts, USPH has a Buy consensus rating as of Nov 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $110.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $110.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

U.S. Physical Therapy (USPH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.